Migraine

FDA Accepts NDA for DHE STS101 Nasal Powder Product for Acute Migraine

by

The FDA accepted Satsuma Pharmaceuticals 505(b)(2) New Drug Application (NDA) for its investigational new dihydroergotamine (DHE) nasal powder product, STS101, for the acute treatment of migraine. The agency is expected to make a decision on the therapy by January 2024.1 “We are proud to announce the FDA acceptance for review of our NDA STS101, as … Read more

Why you get headaches after working out and what you can do to prevent it

by

fOr some people, going for a run can trigger what\’s known as a runner\’s high, a short-lived feeling of euphoria or relaxation. But for others, running can trigger something far less pleasant: a headache. Exercise or exertion headaches were first described by researchers in 1968. They occur during or after a period of intense, strenuous … Read more